166 related articles for article (PubMed ID: 22367324)
1. Validation of the FIGO 2009 staging system for carcinoma of the vulva.
Tan J; Chetty N; Kondalsamy-Chennakesavan S; Crandon A; Garrett A; Land R; Nascimento M; Nicklin J; Perrin L; Obermair A
Int J Gynecol Cancer; 2012 Mar; 22(3):498-502. PubMed ID: 22367324
[TBL] [Abstract][Full Text] [Related]
2. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
[TBL] [Abstract][Full Text] [Related]
4. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
[TBL] [Abstract][Full Text] [Related]
6. Validation of the new FIGO staging system (2009) for vulvar cancer in the Chinese population.
Li J; Cai Y; Ke G; Xiang L; Wang L; Yang W; Wu X; Yang H
Gynecol Oncol; 2015 May; 137(2):274-9. PubMed ID: 25759305
[TBL] [Abstract][Full Text] [Related]
7. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
Rosendahl M; Høgdall CK; Mosgaard BJ
Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
[TBL] [Abstract][Full Text] [Related]
8. A comparison of staging systems for squamous cell carcinoma of the vulva.
Hopkins MP; Reid GC; Johnston CM; Morley GW
Gynecol Oncol; 1992 Oct; 47(1):34-7. PubMed ID: 1427397
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system.
Seward S; Ali-Fehmi R; Munkarah AR; Semaan A; Al-Wahab ZR; Elshaikh MA; Cote ML; Morris RT; Bandyopadhyay S
Int J Gynecol Cancer; 2012 Mar; 22(3):452-6. PubMed ID: 22274544
[TBL] [Abstract][Full Text] [Related]
10. Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review.
Seidman JD; Yemelyanova A; Cosin JA; Smith A; Kurman RJ
Int J Gynecol Cancer; 2012 Mar; 22(3):367-71. PubMed ID: 22237384
[TBL] [Abstract][Full Text] [Related]
11. [The reasons of changes in revised staging for carcinoma of the vulva].
Sehnal B; Kmoníčková E; Maxová K; Koutníková H; Driák D; Neumannová H; Bolehovská P; Sláma J
Klin Onkol; 2013; 26(5):319-22. PubMed ID: 24107153
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical versus surgical staging systems in vulvar cancer.
Shanbour KA; Mannel RS; Morris PC; Yadack A; Walker JL
Obstet Gynecol; 1992 Dec; 80(6):927-30. PubMed ID: 1448261
[TBL] [Abstract][Full Text] [Related]
13. Staging for vulvar cancer.
Hacker NF; Barlow EL
Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):802-11. PubMed ID: 25842047
[TBL] [Abstract][Full Text] [Related]
14. New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis.
van der Steen S; de Nieuwenhof HP; Massuger L; Bulten J; de Hullu JA
Gynecol Oncol; 2010 Dec; 119(3):520-5. PubMed ID: 20875914
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the 2009 FIGO staging for endometrial cancer: an illustration of the E3N cohort.
Koskas M; Chabbert-Buffet N; Bendifallah S; Luton D; Clavel-Chapelon F; Rouzier R
Int J Gynecol Cancer; 2012 Mar; 22(3):447-51. PubMed ID: 22367322
[TBL] [Abstract][Full Text] [Related]
16. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
[TBL] [Abstract][Full Text] [Related]
17. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer.
Tantipalakorn C; Robertson G; Marsden DE; Gebski V; Hacker NF
Obstet Gynecol; 2009 Apr; 113(4):895-901. PubMed ID: 19305336
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma.
Micheletti L; Preti M; Cintolesi V; Corvetto E; Privitera S; Palmese E; Benedetto C
J Gynecol Oncol; 2018 Sep; 29(5):e61. PubMed ID: 30022627
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis.
Zhou J; Shan G
Curr Med Res Opin; 2016 Jun; 32(6):1121-30. PubMed ID: 26959073
[TBL] [Abstract][Full Text] [Related]
20. A suggested modification to FIGO stage III vulvar cancer.
Rouzier R; Preti M; Sideri M; Paniel BJ; Jones RW
Gynecol Oncol; 2008 Jul; 110(1):83-6. PubMed ID: 18436291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
